Development of FAPI PET as a Non-invasive Biomarker of Pulmonary Fibrogenesis
NCT06940427
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Fibrosis Lung
Interventions
DRUG:
FAPI tracer
DEVICE:
PET/MRI
Sponsor
University of Wisconsin, Madison